Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 19, Issue 2, Pages 340-350
Publisher
Wiley
Online
2014-10-21
DOI
10.1111/jcmm.12444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
- (2015) Hayato Fujita et al. NEOPLASIA
- Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer
- (2013) K Eto et al. BRITISH JOURNAL OF CANCER
- Pancreatic cancer
- (2013) C Güngör et al. BRITISH JOURNAL OF PHARMACOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- B7H4, HSP27 and DJ-1 molecular markers as prognostic factors in pancreatic cancer
- (2013) A. Tsiaousidou et al. PANCREATOLOGY
- Re-resection for Isolated Local Recurrence of Pancreatic Cancer is Feasible, Safe, and Associated with Encouraging Survival
- (2012) Oliver Strobel et al. ANNALS OF SURGICAL ONCOLOGY
- Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update
- (2012) Daniel R. Ciocca et al. ARCHIVES OF TOXICOLOGY
- Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
- (2012) Todd M. Bauer et al. CANCER
- Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
- (2012) Ross A. Soo et al. CURRENT DRUG TARGETS
- miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
- (2012) Hai-jiao Yan et al. DIGESTIVE DISEASES AND SCIENCES
- Small heat shock proteins in cancer therapy and prognosis
- (2012) Amina Zoubeidi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death
- (2012) Julie Acunzo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Small heat shock proteins and the cytoskeleton: An essential interplay for cell integrity?
- (2012) G. Wettstein et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
- (2012) Takeshi Ishikawa et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
- (2012) Katharina Elisabeth Tschoep-Lechner et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
- (2011) Kenoki Ohuchida et al. ANNALS OF SURGICAL ONCOLOGY
- Overcoming drug resistance in pancreatic cancer
- (2011) Jiang Long et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer-A review
- (2011) Sameer Dhayat et al. INTERNATIONAL JOURNAL OF CANCER
- Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
- (2011) Claus Schäfer et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer
- (2011) Sergio Maluta et al. STRAHLENTHERAPIE UND ONKOLOGIE
- OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer
- (2011) V Baylot et al. Cell Death & Disease
- Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
- (2010) S. Bünger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Effect of hyperthermia in combination with TRAIL on the JNK-Bim signal transduction pathway and growth of xenograft tumors
- (2010) Marco A. Alcala et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Gemcitabine remains the standard of care for pancreatic cancer
- (2010) Jordan Berlin et al. Nature Reviews Clinical Oncology
- Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma
- (2009) Qiaojia Huang et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience
- (2009) Takayuki Ohguri et al.
- Hyperthermia adds to chemotherapy
- (2008) Rolf D. Issels EUROPEAN JOURNAL OF CANCER
- Genes and genetic networks responsive to mild hyperthermia in human lymphoma U937 cells
- (2008) Yoshiaki Tabuchi et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Endoplasmic reticulum stress and the pancreatic acinar cell
- (2008) Constanze H Kubisch et al. Expert Review of Gastroenterology & Hepatology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started